FDA Commissioner Dr. Marty Makary and FDA Director of the Center for Biologics Evaluation and Research Dr. Vinay Prasad–both oncologists by training–have announced the FDA will be greatly narrowing its approval for annual COVID vaccination to adults over age 65 and those with broadly-defined high-risk features (listed in figure 2) to mirror policies of European nations. | Prasad & Makary, N Engl J Med 2025
